1H,1H,7H-Dodecafluoroheptyl acrylate, 98.0%, 25g

2-Bromo-6-chloroanisole, 95.0%, 10g

5-(4-Chloro-phenyl)-pyridin-2-ol, 95.0%, 5g

4,6-difluoro-N-[3-(1H-imidazol-1-yl)propyl]-1,3-benzothiazol-2-amine, 95.0%, 500mg

Ethyl 4-bromothiophene-3-carboxylate, 97%, 5g

ethyl 1-[(4-methoxyphenyl)methyl]-4-oxo-1H,2H,4H-pyrazolo[3,4-b]pyridine-5-carboxylate, 99.29%, 100mg

3-Bromo-1H-pyrazol-4-amine, 95.0%, 10g

2-(4-(Benzyloxy)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

2-(2-ethyl-1H-imidazol-1-yl)ethanol, 95.0%, 1g

Decamethyltetrasiloxane, 95%, 500g

1H-Imidazole-4-carbaldehyde, 95.0%, 100g

Methyl 3-amino-6-bromopyrazine-2-carboxylate, 95.0%, 25g

Orotic acid monohydrate, min. 99%, 250 g, plastic packaging.